PolyMedix, Inc. is focused on treating life threatening acute cardiovascular disorders and infectious diseases with synthetic small molecule compounds that mimic the activity of large natural protein molecules, compounds referred to as biomimetics.
|Last Price N/A||Change $ N/A||Change % N/A||Tick N/A|
|Bid N/A||Bid Size N/A||Ask N/A||Ask Size N/A|
|Open N/A||High N/A||Low N/A||Prev Close N/A|
|Last Trade||Volume 0||52 Wk Hi 0.017||52 Wk Low 0.|
|Market Cap N/A||Ex-Div Date N/A||Div Rate N/A||Yield N/A|
|Shares 2,135,827.00||EPS (TTM) N/A||PE Ratio N/A||Exchange OTCPK|
|Current||1 Month Ago||2 Months Ago||3 Months Ago|